Quadriga BioSciences
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
339 S San Antonio Rd Ste 2A, Los Altos, ...Phone Number
(650) 917-9098Website
www.quadrigabiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Quadriga BioSciences
Quadriga BioSciences, Inc. is focused on advancing novel oncology therapeutics, particularly through the development of QBS72S, a first-in-class chemotherapeutic agent. This innovative drug utilizes the L-type Amino Acid Transporter 1 (LAT1) to cross the blood-brain barrier and target rapidly growing cancer cells. QBS72S mimics the structure of an aromatic amino acid, allowing it to enter cancer cells and induce cell death by forming DNA interstrand cross-links. The company aims to partner with others in the oncology field to further its mission.Explore more
Quadriga BioSciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quadriga BioSciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Quadriga BioSciences has new funding data
Quadriga BioSciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Quadriga BioSciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Quadriga BioSciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Quadriga BioSciences had a recent Job posting/layoffs
Product Launch: Get notified when Quadriga BioSciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Quadriga BioSciences
Earning: See what the market has to say on Quadriga BioSciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Quadriga BioSciences
Compare insights from companies similar to Quadriga BioSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Quadriga BioSciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Quadriga BioSciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Quadriga BioSciences.
Quadriga BioSciences Tech Stack
A closer look at the technologies used by Quadriga BioSciences
Quadriga BioSciences News & Media
Quadriga BioSciences Announces Dosing of First Subject in Phase 2 Study Evaluating QBS72S For Brain Metastases of Breast Cancer
LOS ALTOS, Calif., April 11, 2023 /PRNewswire/ -- Quadriga BioSciences, a clinical-stage oncology company developing QBS10072S (QBS72S) for the targeted treatment of cancer, today announced the dosing of the first subject in a Phase 2 study evaluating QBS72S for the treatment of brain...Quadriga BioSciences Announces Dosing of First Subject in Phase 2 Study Evaluating QBS72S For Glioblastoma
LOS ALTOS, Calif., Feb. 14, 2023 /PRNewswire/ -- Quadriga BioSciences, a clinical-stage oncology company developing QBS10072S (QBS72S) for the targeted treatment of cancer, today announced the dosing of the first subject with QBS72S in the Phase 2 INSIGhT study, evaluating QBS72S against...Quadriga BioSciences Announces Completion of Enrollment in Phase 1 Study of QBS72S for Solid Tumors
- Findings from Phase 1 study to support the launch of two SBIR-funded Phase 2 studies of QBS72S for brain malignancies LOS ALTOS, Calif., Oct. 25, 2022 /PRNewswire/ -- Quadriga BioSciences, a clinical-stage oncology company developing QBS10072S (QBS72S) for the targeted treatment of...Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
First-in-class, dual-function, small molecule drug utilizes LAT1 amino acid transporter pathway to cross blood-brain barrier and deliver warhead directly into cancer cells, a potential breakthrough in brain cancer treatment
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quadriga BioSciences
Sign Up For FreeTo access detailed company insights
Quadriga BioSciences, Inc. is focused on advancing novel oncology therapeutics, particularly through the development of QBS72S, a first-in-class chemotherapeutic agent. This innovative drug utilizes the L-type Amino Acid Transporter 1 (LAT1) to cross the blood-brain barrier and target rapidly growing cancer cells. QBS72S mimics the structure of an... Read More
